The Scientist article by Monique Brouillette describing exo-AAV for immune evasion

May 2019: Nice blog on addgene by Klaus Wanisch describing the exo-AAV system

MGH Research Institute story about our research

Article about therapies that cross the BBB in TheScientist.

Harvard Medical School press release regarding our work using exo-AAV for deafness gene therapy

Commentary on our article using exo-AAV to treat hereditary deafness


December 16, 2016

Editorial Highlight for our recent article describing the interaction of AAV9 with a model of the human blood-brain barrier.


August 1, 2016

The Maguire lab was awarded a Partners Innovation Discovery Grant to develop the vexosome gene delivery platform for gene therapy of deafness

March 19, 2016

Funding from Cure Alzheimer's Fund to develop novel gene therapy for AD treatment


February 21, 2015

Article in Australian "the Saturday Paper" regarding the current state of gene therapy

February 9, 2015

Maguire Lab alum Zachary Fitzpatrick awardeda 2015 Gates Cambridge Scholarship


September 12, 2014

Link to article about CRISPR technology and potential for therapy.

May 23, 2014

At the 2014 American Society of Gene and Cell Therapy Meeting the Maguire Lab won "Outstanding Poster Presentation" on back to back nights for:

1. Poster 60.  Vesicle-cloaked AAV resists neutralizing antibodies in vivo.

  Zachary Fitzpatrick, Dakai Mu, Casey A. Maguire

2. Poster 297. Enhancing AAV9 transduction and multi-capsid packaging using extracellular vesicles.

Bence Gyorgy, Zachary Fitzpatrick, Dakai Mu, Casey A. Maguire